ÃâÒßѧÊÔÌâ
U*6r".sz Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
Oh|Hy/&6W 1. Fas(CD95)/FasL
|=SaI%%Be 2. common chain of cytokine receptor
gHTo|2 Q{ 3 . TCR/CD3 complex
<%|2yPb] 4. negaive selection of thymocytes
:imp~~L; 5. artificial active immune
rHP5;j<] 6. anti-idiotypic
L"AZ,|wIk 7. IgSF
iLgWzA 8. Integrin
)4DF9 JpD 9. chemokine
Zj$U_ 10. B7/CD28
kMK-
E
<g ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
'./s'!Lj 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
L g-Sxz}P! 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
O{Wy;7i 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
_%Jqyc"- 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
/-1[}h%U'
u>d,
6
! 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
4R.rSsAH µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
IE,
xiV Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
U }xRvNz 1. B7/CD28
Ub0g{ 2. Th1 subset
8eQ 4[wJY 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
L-vy,[9)[* 4. antibody affinity maturation
j#zUO&Q@ 5. AP-1
3y<;fdS7 6. single chain variable fragment£¨ScFv£©
HOBM?|37CU 7. NK cell receptor
F^z&s]^~ 8. Zinkernagel-Doherty phenomenon
Xb.
WI\Eh 9. Ig fold
kg1z"
EE 10. CD40/CD40L
UTC|8 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
G?v]p~6 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
@WED
XB 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
z^'3f!:3 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
1#/>[B Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
+a
0q?$\ 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
+O8rjVg) 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
Db3#; 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
C5"=%v[gQv Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
xJlf}LEyF £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
[Wf% iwB Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
L"e8S%UqX 1.Co-stimulators (or co-stimulating molecules)
> yk2 2.NK-kB
SoC3)iqv/ 3.Immunoglobulin superfamily
7|bzopLJk 4.antigen-presenting cell (APC)
*jE>(J` 5.death domain
}04EM 6.CCR and CXCR
-!4Mmp"2@u 7.Lectin (or mitogen)
xL&M8: 8.Clusters of differentiation, CD)
kn9ul3c 9.B7 family
&BxDS
. 10.Cytotoxic T lymphocyte, CTL)
v{tw ;Z# 11.IL-15 and IL-15 receptor (IL-15R)
u2\QhP 9 12.MHC restriction
jAXKp
b 13.Affinity-chromatography
e,V @t% 14.Cyctosprin A, CsA
N5K\h}'% 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
csK;GSp} ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
aq,Ab~V] 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
|f67aN 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
m!#'4 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
K)DpC* j Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
}aSTo"~m# ÃâÒßѧרҵ£º
6 rp(<D/_ 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
v=8sj{g3,3 Ïû»¯ÄÚ¿Æ£º
[[FDt[ l4 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
4 x|yzUx ѪҺ²¡Ñ§×¨Òµ£º
:d)y 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
+%sMd]$,n Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
^L?2y/ (רҵ»ù´¡: ÃâÒßѧ)
<Dk6o`7^N Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
'LX]/D 1. ADCC(antibody dependent cell-mediated cytotoxicity)
+Z7:(o< 2. »·æß¾úËØ(cyclosporin)
~CX1WPMI: 3. KIR(killer cell inhibitory receptor)
OrPi ("/ 4. HLDA(human leucocyte differentiation antigen)
jCp^CNbA 5. Interleukin 18(IL-18)
T;C0t9Yew 6. ÕûºÏËØ(integrin)
)i/x%^ca$ 7. Fas/FasL
Bcl6n@{2f 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
SX1w5+p$C 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
as^!c! 10. Th1/Th2
;Z 6ngS 11. »ùÒòÒßÃç(DNAÒßÃç)
+wIv|zj9 12. chemokines and chemokine receptor
}'u0Q6Obj 13. ÃâÒßÄÍÊÜ
AGGNJ4m 14. ¹²´Ì¼¤·Ö×Ó
4{6XZ_J1 15. ËÀÍö½á¹¹Óò(death domain)
jJqq:.XqB8 ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
wA< Fw
) 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
;d<RPVE: 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
68QA%m'J £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
/NB;eV? £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
A
GMrBd|J{ £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
_>u0vGF- £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
yL#2|t( 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
p<8Ga.kiN Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
;t5e] ÎÊ´ðÌâ(ÿÌâ25·Ö)
4n}^1eQ9 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
rssn'h 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
K!qV82b='{ 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
R}0xWPt9G 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£